- Home
- KAPA vs EDUC Comparison
KAPA vs EDUC Comparison
Compare KAPA & EDUC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KAPA
- EDUC
- Stock Information
- Founded
- KAPA 2013
- EDUC 1965
- Country
- KAPA United States
- EDUC United States
- Employees
- KAPA N/A
- EDUC N/A
- Industry
- KAPA
- EDUC Consumer Specialties
- Sector
- KAPA
- EDUC Consumer Discretionary
- Exchange
- KAPA NYSE
- EDUC Nasdaq
- Market Cap
- KAPA 10.8M
- EDUC 11.4M
- IPO Year
- KAPA 2024
- EDUC N/A
- Fundamental
- Price
- KAPA $1.10
- EDUC $1.34
- Analyst Decision
- KAPA Strong Buy
- EDUC
- Analyst Count
- KAPA 3
- EDUC 0
- Target Price
- KAPA $8.33
- EDUC N/A
- AVG Volume (30 Days)
- KAPA 13.5M
- EDUC 7.3K
- Earning Date
- KAPA 08-23-2025
- EDUC 07-07-2025
- Dividend Yield
- KAPA N/A
- EDUC N/A
- EPS Growth
- KAPA N/A
- EDUC N/A
- EPS
- KAPA N/A
- EDUC N/A
- Revenue
- KAPA N/A
- EDUC $31,304,000.00
- Revenue This Year
- KAPA N/A
- EDUC N/A
- Revenue Next Year
- KAPA N/A
- EDUC N/A
- P/E Ratio
- KAPA N/A
- EDUC N/A
- Revenue Growth
- KAPA N/A
- EDUC N/A
- 52 Week Low
- KAPA $0.40
- EDUC $0.92
- 52 Week High
- KAPA $4.00
- EDUC $2.49
- Technical
- Relative Strength Index (RSI)
- KAPA N/A
- EDUC 48.99
- Support Level
- KAPA N/A
- EDUC $1.26
- Resistance Level
- KAPA N/A
- EDUC $1.37
- Average True Range (ATR)
- KAPA 0.00
- EDUC 0.07
- MACD
- KAPA 0.00
- EDUC -0.00
- Stochastic Oscillator
- KAPA 0.00
- EDUC 54.22
About KAPA KAIROS PHARMA LTD
Kairos Pharma Ltd is a clinical-stage biopharmaceutical company. It is engaged in therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance. These therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma.
About EDUC Educational Development Corporation
Educational Development Corp is the United States trade publisher of the line of educational children's books produced in the United Kingdom. Its business activity functions with two reportable segments: PaperPie and Publishing. The Publishing Division segment markets its products to retail accounts, which include books, school supplies, toy and gift stores and museums, through commissioned sales representatives, trade and specialty wholesalers and an internal telesales group.